Treatment of high-grade glioma in children and adolescents. - Wikidata - awgldk - TriplyDB

Treatment of high-grade glioma in children and adolescents.

Treatment of high-grade glioma in children and adolescents.

http://www.wikidata.org/entity/Q37904503

about

A Systematic Review on the Characteristics, Treatments and Outcomes of the Patients with Primary Spinal Glioblastomas or Gliosarcomas Reported in Literature until March 2015 Molecular Biology in Pediatric High-Grade Glioma: Impact on Prognosis and Treatment Molecular characteristics of pediatric high-grade gliomas Cellular immunotherapy for pediatric solid tumors Nimotuzumab enhances temozolomide-induced growth suppression of glioma cells expressing mutant EGFR in vivo ABT-263 enhances sensitivity to metformin and 2-deoxyglucose in pediatric glioma by promoting apoptotic cell death An individual patient data meta-analysis on characteristics, treatments and outcomes of the glioblastoma/gliosarcoma patients with central nervous system metastases reported in literature until 2013.Advances in the management of paediatric high-grade glioma.An individual patient data meta-analysis on characteristics, treatments and outcomes of glioblastoma/ gliosarcoma patients with metastases outside of the central nervous system.Pre-B-cell leukemia homeobox interacting protein 1 is overexpressed in astrocytoma and promotes tumor cell growth and migration.Penfluridol suppresses glioblastoma tumor growth by Akt-mediated inhibition of GLI1.Dissecting DNA repair in adult high grade gliomas for patient stratification in the post-genomic era.Differences in molecular genetics between pediatric and adult malignant astrocytomas: age matters.Reirradiation as part of a salvage treatment approach for progressive non-pontine pediatric high-grade gliomas: preliminary experiences from the German HIT-HGG study group.Managing chemotherapy-related cardiotoxicity in survivors of childhood cancers.Inhibition of Pediatric Glioblastoma Tumor Growth by the Anti-Cancer Agent OKN-007 in Orthotopic Mouse Xenografts.Pediatric glioma stem cells: biologic strategies for oncolytic HSV virotherapy The histone deacetylase inhibitor PCI-24781 as a putative radiosensitizer in pediatric glioblastoma cell lines.Exomic sequencing of four rare central nervous system tumor types Phase II study of cilengitide in the treatment of refractory or relapsed high-grade gliomas in children: a report from the Children's Oncology Group.Downregulation of miR-137 and miR-6500-3p promotes cell proliferation in pediatric high-grade gliomas.Pediatric Brain Tumors: Current Knowledge and Therapeutic Opportunities Anti-cancer Therapies in High Grade Gliomas.Treatment of children with high grade glioma with nimotuzumab: a 5-year institutional experience Current Trends and Healthcare Resource Usage in the Hospital Treatment of Primary Malignant Brain Tumor in Japan: A National Survey Using the Diagnostic Procedure Combination Database (J-ASPECT Study-Brain Tumor).Pediatric neuro-oncology: current status and future directions.The molecular landscape of pediatric brain tumors in the next-generation sequencing era.Outcome of young children with high-grade glioma treated with irradiation-avoiding intensive chemotherapy regimens: Final report of the Head Start II and III trials.Novel Approaches to Apoptosis-Inducing Therapies.RIST: a potent new combination therapy for glioblastoma.Molecular characterization reveals NF1 deletions and FGFR1-activating mutations in a pediatric spinal oligodendroglioma.Commentary on: "A Multi-Institutional Experience in Pediatric High Grade Glioma".Evaluating extent of resection in pediatric glioblastoma: a multiple propensity score-adjusted population-based analysis.Pediatric glioblastoma: a single institution experience.Secondary Solid Malignancies After High-Grade Glioma Treatment in Pediatric Patients.Next generation sequencing as an aid to diagnosis and treatment of an unusual pediatric brain cancer.Treatment options in newly diagnosed glioblastoma.The State of Cellular Adoptive Immunotherapy for Neuroblastoma and Other Pediatric Solid Tumors.H3.3K27M Cooperates with Trp53 Loss and PDGFRA Gain in Mouse Embryonic Neural Progenitor Cells to Induce Invasive High-Grade Gliomas.Selective BCL-XL inhibition promotes apoptosis in combination with MLN8237 in medulloblastoma and pediatric glioblastoma cells.

P2860

Q26767359-8CEC13D9-9255-451A-98C5-4074D69BAA86 Q26785952-02411801-95F4-490F-831E-DF04A6024778 Q26860786-6D637897-BE79-4512-8FAA-45EC0D452408 Q27014912-73D701C1-83BD-49C2-B7B6-B192F9A76693 Q27853322-6E2576DB-8405-4357-B294-F258723C1A49 Q28488211-99A66E66-F521-4FC5-AC00-C1EC0347239F Q30845275-8C8F6F03-8622-4BC2-80E5-39FD3C465365 Q30870633-CD0301E3-07DF-4D00-943B-B61E3526E1B3 Q30929161-A752059A-A9C9-435D-8741-8FFF326122C8 Q33753458-83BEFDB5-DDC6-4A5C-A1D3-3E53D8CD54B3 Q33779323-00711F5E-242E-4640-897E-53E576146CE6 Q34221722-E2CF74A3-A3DD-4AD6-8370-5DC29C8340D9 Q34286305-25FD4D3A-680C-44D8-B204-B6D399131E30 Q34812560-32291D7C-B851-4EA7-B81D-BD35C4C8C258 Q35562745-B9B6C01B-EA39-4B4B-A488-81770FDA6CB6 Q35738941-AFBDB9D2-EA8D-403E-BC5C-1B5B4EFC678D Q36644898-2E0E78E8-A941-45C2-988F-4323F80EA6FE Q36810416-FB8C64C5-4354-4381-91DB-5847CA81E5A3 Q37038397-383EC059-B1E1-403C-BD4B-1F2B2213265F Q37187676-BAFD6822-3D66-4382-8DCF-2DD23DD40F49 Q37190159-3EEFCDB1-F24A-4C7E-8791-5EAFE23099C4 Q37213305-73B25DEA-8E44-4207-ABB9-4DC30BDE2625 Q37290626-7E92850D-BF16-4795-8144-55B1FE972F65 Q37484213-DFEAD3D0-E75A-45A4-86DA-AEDA261B5E24 Q37573695-30DD862C-42F6-47A6-829B-4751C8B57B2F Q38035070-61B03C3C-6474-4461-A9DE-1991E77930C6 Q38231122-48B2BE01-8748-4CC9-9EA6-C4324B7D470B Q38873292-05C02947-E5F0-4DD6-ADCF-101A7E016CDB Q38936710-C5E46D5B-03B3-4734-8728-D247E65F2861 Q38966022-DCAA69AE-5DC3-4D55-960D-B5FAEAC6910B Q39174603-F557E8EC-3A3A-4CF0-AFD4-65A9A029D6BF Q39376191-A98F1B41-6994-4D99-B4C9-E181EF46D3ED Q40107689-75ED8897-472D-4F9C-AEEF-3764FEE2DD6A Q40355125-1B7A2C32-ED85-4D31-825B-818064908807 Q41519389-74297442-A0B4-474E-8390-D5CA34398B32 Q42242778-DCCAF7DC-76FA-4D8A-A056-DB1F3FC45606 Q44532006-9DCD7F78-63E3-4FE4-A56D-4152E016CF26 Q47114749-2403C822-4E95-45B2-BCD8-29961C07804E Q47436402-329F19D9-DA08-4A9B-91AF-590B17F30251 Q47671054-9F35D4A1-1BEE-46C4-8BEB-7E366D047479

P2860

Treatment of high-grade glioma in children and adolescents.

http://www.wikidata.org/entity/Q37904503

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 22 July 2011

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Treatment of high-grade glioma in children and adolescents.

@en

Treatment of high-grade glioma in children and adolescents.

@nl

type

label

Treatment of high-grade glioma in children and adolescents.

@en

Treatment of high-grade glioma in children and adolescents.

@nl

prefLabel

Treatment of high-grade glioma in children and adolescents.

@en

Treatment of high-grade glioma in children and adolescents.

@nl

P1433

Q37904503-D9BF73A5-BEF3-4C97-A68B-217135D80FAA

P1476

Q37904503-24266ED2-D56F-4461-9F5C-2DA4D5998326

P2093

Q37904503-2CE80E67-5049-4B97-BB8C-6115739EE457

Q37904503-51B43976-1D5E-4FCD-8706-69A7D0D746DA

Q37904503-FA30721D-9022-4E44-9F9B-FB8B30FDA205

P2860

Q37904503-00DD14A5-53F2-4B99-9C61-0F50105845AC

Q37904503-0EAE78D9-C565-4A22-A1F5-23D907F44B9E

Q37904503-0EBF3691-54C2-407E-91B9-B12373EA00C8

Q37904503-10832CFC-3B0C-4CAB-AB18-A3A508F8BB2E

Q37904503-13019B25-9BDD-4E3A-9F65-7C33E89667F5

Q37904503-1516F30F-B2F8-421C-9F38-D99EDE7BC624

Q37904503-173E6F8E-3B9A-495E-A0C8-E235370AE9C1

Q37904503-183047C4-5E7D-44CC-A84E-489D7B8D700F

Q37904503-19BA72A7-E260-4868-AC7F-20904AD6145A

Q37904503-1E502926-816F-4EFD-96A4-0793476C327B

P304

Q37904503-B7BDD062-3F13-4C55-BCC7-D0C1F3386E30

P31

Q37904503-B3C2CEEE-55CD-4B66-B300-2875993A8C7C

P356

Q37904503-CF5F0C2F-13DE-4A99-81F3-F15A81139465

P433

Q37904503-C4A9DADE-D5A9-4CA0-8124-044C219E0763

P478

Q37904503-61228578-222F-4283-800E-C0D16AE67B42

P577

Q37904503-4E241F12-FD15-4B4B-9A62-0E7BE474D5C7

P5875

Q37904503-1E1C6A92-7BBD-4E46-BB10-026B0F78CFDC

P698

Q37904503-B546BBD6-0F13-46EA-A792-F94CA5C59CDE

P921

Q37904503-A0D0C5A5-2C81-4D7D-8D84-8AE12B03D316

P932

Q37904503-793D9664-94F9-41DC-B044-554312B8A0B1

P356

P1433

P1476

Treatment of high-grade glioma in children and adolescents.

@en

P2093

C M Kramm

http://www.w3.org/2001/XMLSchema#string

D Aguilera

http://www.w3.org/2001/XMLSchema#string

T J MacDonald

http://www.w3.org/2001/XMLSchema#string

P2860

The 2007 WHO classification of tumours of the central nervous system

MGMT gene silencing and benefit from temozolomide in glioblastoma.

Integrins in cancer: biological implications and therapeutic opportunities

Population-based epidemiologic data on brain tumors in German children.

Diffuse brainstem glioma in children: critical review of clinical trials.

Progression-associated genes in astrocytoma identified by novel microarray gene expression data reanalysis.

Safety and pharmacokinetics of temozolomide using a dose-escalation, metronomic schedule in recurrent paediatric brain tumours.

Phase 2 study of temozolomide in children and adolescents with recurrent central nervous system tumors: a report from the Children's Oncology Group.

A phase II study of the farnesyl transferase inhibitor, tipifarnib, in children with recurrent or progressive high-grade glioma, medulloblastoma/primitive neuroectodermal tumor, or brainstem glioma: a Children's Oncology Group study.

Phase I trial of single-dose temozolomide and continuous administration of o6-benzylguanine in children with brain tumors: a pediatric brain tumor consortium report.

P304

1049-1058

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/NEUONC/NOR092

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P577

2011-07-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51517070

http://www.w3.org/2001/XMLSchema#string

P698

21784756

http://www.w3.org/2001/XMLSchema#string

P921

P932

3177659

http://www.w3.org/2001/XMLSchema#string